In 2024, the net profit of one of the largest pharmaceutical producers of Ukraine, in 2024, amounted to more than UAH 1.6 billion, indicate the official financial results of the enterprise, published on the Opendatabot portal.
According to TSN, compared to the previous year, the company's profit increased by UAH 100 million, since in 2023 it amounted to more than 1.5 billion UAH. In 2022, Pharmak declared a profit of UAH 1.3 billion, which indicates a steady increase in the company's financial performance over the last three years.
The company takes an important position in the pharmaceutical market of Ukraine. In recent years, Pharmak has strengthened his leading positions through the diversification of the product portfolio and an effective development strategy. Experts estimate that up to 75% of the final cost of the medicine consists of a manufacturer's selling price, which makes it a major element in structuring the price for medicines. From March 1, 2025, state regulation of prices for a number of popular medicines will be introduced in Ukraine. This decision made by the NSDC and the Government provides for a reduction in the cost of more than a hundred medicines by 30%. The list of drugs that would be set by prices was agreed with the manufacturers, and each drug was discussed separately. However, such an initiative has been criticized by some experts. They indicate the absence of a transparent mechanism for the formation of the list of regulation drugs, and pay attention to the fact that the main focus in regulation is placed on the limitation of margins for distributors and pharmacies, while the formation of a basic price is left out of control.
Given the steady increase in the Farmac financial indicators and changes in the pharmaceutical market, the company will have to adapt its strategy to new conditions, in particular in the conditions of state regulation of prices for medicines. Therefore, the issue of efficiency in such conditions will remain key for pharmaceutical manufacturers, including the industry leader - Pharmak.
